hydroxyflutamide has been researched along with trelstar in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bélanger, A; Couture, J; Cusan, L; Dupont, A; Giasson, M; Labrie, F | 1 |
1 other study(ies) available for hydroxyflutamide and trelstar
| Article | Year |
|---|---|
Plasma levels of hydroxy-flutamide in patients with prostatic cancer receiving the combined hormonal therapy: an LHRH agonist and flutamide.
Topics: Adult; Aged; Anilides; Antineoplastic Combined Chemotherapy Protocols; Flutamide; Gonadotropin-Releasing Hormone; Humans; Kinetics; Male; Middle Aged; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1988 |